Benno J W M Rensing
Overview
Explore the profile of Benno J W M Rensing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Royen N, Amat-Santos I, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, et al.
EuroIntervention
. 2024 Nov;
21(2):e105-e118.
PMID: 39589296
Background: There are limited head-to-head randomised trials comparing the performance of different transcatheter heart valves (THVs). Aims: We aimed to evaluate the non-inferiority of the balloon-expandable Myval THV series compared...
2.
Hegeman R, van Putten S, Timmers L, Rensing B, Sonker U, Laengle S, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458162
: Paravalvular leak and permanent pacemaker implantation remain relevant issues after transcatheter aortic valve implantation (TAVI). Novel device development as well as adequate preprocedural device selection can contribute to optimal...
3.
Maarse M, Seiffge D, Werring D, Boersma L, Aarnink E, Fierro N, et al.
JAMA Neurol
. 2024 Oct;
PMID: 39374446
Importance: Patients with atrial fibrillation (AF) who have ischemic stroke despite taking oral anticoagulation therapy (OAT) have a very high risk of recurrence. Left atrial appendage occlusion (LAAO) is a...
4.
van Ginkel D, Bor W, Aarts H, Dubois C, De Backer O, Rooijakkers M, et al.
N Engl J Med
. 2024 Aug;
392(5):438-449.
PMID: 39216096
Background: One third of patients undergoing transcatheter aortic-valve implantation (TAVI) have an indication for oral anticoagulation owing to concomitant diseases. Interruption of oral anticoagulation during TAVI may decrease the risk...
5.
Baumbach A, van Royen N, Amat-Santos I, Hudec M, Bunc M, Ijsselmuiden A, et al.
Lancet
. 2024 May;
403(10445):2695-2708.
PMID: 38795719
Background: Transcatheter aortic valve implantation is an established, guideline-endorsed treatment for severe aortic stenosis. Precise sizing of the balloon-expandable Myval transcatheter heart valve (THV) series with the aortic annulus is...
6.
Aarnink E, Maarse M, Fierro N, Mazzone P, Beneduce A, Tondo C, et al.
JACC Cardiovasc Interv
. 2024 May;
17(11):1311-1321.
PMID: 38795093
Background: Left atrial appendage occlusion (LAAO) provides mechanical cardioembolic protection for atrial fibrillation (AF) patients who cannot use oral anticoagulation therapy (OAT). Patients with a thrombotic event despite OAT are...
7.
Hegeman R, van Ginkel D, Laengle S, Timmers L, Rensing B, de Kroon T, et al.
Am Heart J
. 2024 Jan;
269:158-166.
PMID: 38163616
Background: Transcatheter aortic valve implantation (TAVI) is an established treatment option for patients with severe aortic valve stenosis, but is still associated with relatively high rates of pacemaker implantation and...
8.
van Ginkel D, Bor W, Dubois C, Aarts H, Rooijakkers M, van Bergeijk K, et al.
EuroIntervention
. 2023 Aug;
19(9):766-771.
PMID: 37605804
About one-third of patients undergoing transcatheter aortic valve implantation (TAVI) use oral anticoagulants (OAC), mainly due to atrial fibrillation. General guidelines advise interrupting OAC in patients with a high risk...
9.
Maarse M, Aarnink E, Huijboom M, Abeln B, Staal D, Rensing B, et al.
Heart Rhythm O2
. 2023 Jun;
4(5):298-308.
PMID: 37323993
Background: Percutaneous left atrial appendage occlusion (LAAO) is an alternative to anticoagulation in the prevention of stroke in patients with nonvalvular atrial fibrillation, especially in patients with a contraindication for...
10.
Bor W, Chan Pin Yin D, Brouwer J, Nijenhuis V, Peper J, Timmers L, et al.
JACC Cardiovasc Interv
. 2021 Jun;
14(11):1265-1267.
PMID: 34112466
No abstract available.